The company received exercise notices from warrant holders to exercise warrants over an aggregate 260,000 shares of common stock, with an exercise price of
Shares in the company closed at
Fri, 16th Mar 2018 18:11
The company received exercise notices from warrant holders to exercise warrants over an aggregate 260,000 shares of common stock, with an exercise price of
Shares in the company closed at
(ShareCast News) - Akers Biosciences has begun to make direct sales of its disposable breath ketone test, Metron, through the Amazon website and via the company's online sales portal. The medical device company said the Metron Breath Ketone Test, which is part of its health and wellness line, is the
Read more(ShareCast News) - Akers Biosciences plummeted after the medical device company said its pre-tax loss widened in the first half as revenue declined. Akers posted a pre-tax loss of $3.41m for the six months ended 30 June, wider than the $1.1m loss in the same period last year. This included a one-tim
Read more